Bod Australia: Continues MediCabilis success
- Bod Australia (BDA) is continuing to experience a significant uptake of its MediCabilis product in Australia
- During April 2020, the medicinal cannabis company filled 516 prescriptions, representing an increase of 35 per cent from the 382 prescriptions filled in March
- This total represents one of the company’s best months on record, coming behind September 2019 when 549 prescriptions filled
- Repeat customers actually accounted for 60 per cent of April’s volume
- The company has now filled 3459 prescriptions in the 2020 financial year
- Bod is down a slight 2.34 per cent and shares are trading for 31.3 cents each just before market close
